Us Bancorp \De\ Passage Bio, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.66 - $6.49 $12,722 - $31,041	-4,783 Reduced 90.54%	500 $2,000
Q4 2021 Feb 11, 2022	BUY	$6.24 - $10.2 $29,845 - $48,786	4,783 Added 956.6%	5,283 $34,000
Q2 2021 Aug 05, 2021	BUY	$12.44 - $19.45 $6,220 - $9,725	500 New	500 $7,000
Q4 2020 Feb 04, 2021	SELL	$14.28 - $29.73 $9,996 - $20,811	-700 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$12.39 - $26.15 $8,673 - $18,305	700 New	700 $9,000

32.7M

8.3K

400

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $38.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.